CHELATION THERAPY

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting CHELATION THERAPY:

# Drug Count
0 DEFERASIROX 6
1 ECULIZUMAB 1
2 ETANERCEPT 1
3 EVOLOCUMAB 1
4 FINASTERIDE 1
5 FLUOXETINE 1
6 FLUOXETINE HYDROCHLORIDE 1
7 INFLIXIMAB 1
8 INSULIN GLARGINE AND LIXISENATIDE 1
9 PALIPERIDONE PALMITATE 1
See all common drugs associated with CHELATION THERAPY

CHELATION THERAPY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INSULIN GLARGINE AND LIXISENATIDE 1 0.0003
1 DEFERASIROX 6 0.0002
2 PALIPERIDONE PALMITATE 1 0.0000
3 TERIFLUNOMIDE 1 0.0000
4 ECULIZUMAB 1 0.0000
5 FINASTERIDE 1 0.0000
6 FLUOXETINE HYDROCHLORIDE 1 0.0000
7 EVOLOCUMAB 1 0.0000
8 INFLIXIMAB 1 0.0000
9 ETANERCEPT 1 0.0000
See all drugs enriched for association with CHELATION THERAPY

CHELATION THERAPY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Iron Chelator [EPC] 6 0.0002
1 PCSK9 Inhibitor [EPC] 1 0.0000
2 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
3 Complement Inhibitor [EPC] 1 0.0000
4 5-alpha Reductase Inhibitor [EPC] 1 0.0000
5 GLP-1 Receptor Agonist [EPC] 1 0.0000
6 Insulin Analog [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
See all drug classes enriched for association with CHELATION THERAPY